Literature DB >> 3244341

Low-level lead exposure, social class, and infant development.

D Bellinger1, A Leviton, C Waternaux, H Needleman, M Rabinowitz.   

Abstract

A prospective cohort study was conducted to assess the association between early development and low-level prenatal and postnatal lead exposure. Infants' performance between 6 and 24 months on the Mental Development Index of the Bayley Scales of Infant Development declined with increasing concentration of lead in blood, but the decline varied with children's age at exposure, level of exposure, and socioeconomic status. Within the second year of life, the performance of children in lower socioeconomic strata was adversely affected at lower levels of prenatal exposure (blood lead levels of 6 to 7 micrograms/dl) than was the performance of children in higher socioeconomic strata. However, even the performance of these advantaged infants was lower when cord blood lead level exceeded 10 micrograms/dl, well below the figure currently regarded as the maximum permissable level for young children. Exploratory analyses suggested that early postnatal blood lead levels between 10 and 25 micrograms/dl were also associated with lower Mental Development Index scores, but only among children in lower socioeconomic strata.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244341     DOI: 10.1016/0892-0362(88)90084-0

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  39 in total

1.  Housing standards: a glossary of housing and health.

Authors:  P Howden-Chapman
Journal:  J Epidemiol Community Health       Date:  2004-03       Impact factor: 3.710

2.  Expanding the scope of environmental risk assessment to better include differential vulnerability and susceptibility.

Authors:  Joel Schwartz; David Bellinger; Thomas Glass
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

3.  Expanding the scope of risk assessment: methods of studying differential vulnerability and susceptibility.

Authors:  Joel Schwartz; David Bellinger; Thomas Glass
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

4.  Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children.

Authors:  Virginia A Rauh; Robin Garfinkel; Frederica P Perera; Howard F Andrews; Lori Hoepner; Dana B Barr; Ralph Whitehead; Deliang Tang; Robin W Whyatt
Journal:  Pediatrics       Date:  2006-11-20       Impact factor: 7.124

5.  Chronic encephalopathies induced by mercury or lead: aspects of underlying cellular and molecular mechanisms.

Authors:  L Rönnbäck; E Hansson
Journal:  Br J Ind Med       Date:  1992-04

6.  Effect of socioeconomic status on exposures to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethylene (DDE) among pregnant African-American women.

Authors:  Luisa N Borrell; Pam Factor-Litvak; Mary S Wolff; Ezra Susser; Thomas D Matte
Journal:  Arch Environ Health       Date:  2004-05

Review 7.  A Systematic Review of the Interplay Between Social Determinants and Environmental Exposures for Early-Life Outcomes.

Authors:  Allison A Appleton; Elizabeth A Holdsworth; Laura D Kubzansky
Journal:  Curr Environ Health Rep       Date:  2016-09

8.  Prepregnancy obesity is associated with lower psychomotor development scores in boys at age 3 in a low-income, minority birth cohort.

Authors:  Amy R Nichols; Andrew G Rundle; Pam Factor-Litvak; Beverly J Insel; Lori Hoepner; Virginia Rauh; Frederica Perera; Elizabeth M Widen
Journal:  J Dev Orig Health Dis       Date:  2019-09-05       Impact factor: 2.401

9.  Analysis of prospective epidemiologic studies on the neurobehavioural effects of lead.

Authors:  R A Volpe; J F Cole; C J Boreiko
Journal:  Environ Geochem Health       Date:  1992-12       Impact factor: 4.609

10.  A survey of the administration of drugs to young infants. The Alspac Survey Team. Avon Longitudinal Study of Pregnancy and Childhood.

Authors:  N Hawkins; J Golding
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.